AMY TEH Portfolio
Invests via Arrowpoint Investment Partners (Singapore) Pte. Ltd. | Managed by AMY TEH
Invests via Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Managed by AMY TEH
Automatically Tracked
AMY TEH Profile
Growth-stage investor and operator focused on scaling technology companies, with hands-on experience across product, strategy and operations. AMY TEH has led venture and private-equity investments in SaaS, fintech and marketplaces, sits on multiple boards and advises founders on go-to-market and unit economics. Known for active portfolio management, deal sourcing in Southeast Asia and structuring follow-on capital.
Growth-stage investor and operator focused on scaling technology companies, with hands-on experience across product, strategy and operations. AMY TEH has led venture and private-equity investments in SaaS, fintech and marketplaces, sits on multiple boards and advises founders on go-to-market and unit economics. Known for active portfolio management, deal sourcing in Southeast Asia and structuring follow-on capital.
Investment Philosophy & Strategy
Growth-stage, hands-on investor focused on scaling technology businesses across SaaS, fintech and marketplaces in Southeast Asia. Prioritises unit-economics-driven go-to-market plays, structured follow-on capital and active board engagement to accelerate product-market fit and durable revenue expansion. Investment style blends operational value-add with disciplined capital allocation, a multi-year growth horizon, selective risk-taking around market-leading founders, and emphasis on repeatable monetisation and scalable distribution channels.
Growth-stage, hands-on investor focused on scaling technology businesses across SaaS, fintech and marketplaces in Southeast Asia. Prioritises unit-economics-driven go-to-market plays, structured follow-on capital and active board engagement to accelerate product-market fit and durable revenue expansion. Investment style blends operational value-add with disciplined capital allocation, a multi-year growth horizon, selective risk-taking around market-leading founders, and emphasis on repeatable monetisation and scalable distribution channels.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
26.79%
Gain +0.94%
Monthly
1.2%
Yearly
15.42%
Drawdown
26.65%
$350.67M
Equity
Holdings
$350.67M
Investment
$330.93M
$4.08M
Profit +$3.92M
Realized
-$15.66M
Unrealized
$19.74M
Dividends
$4.25M
Goals
Avg. 83% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0.94%
Profit
$3.92M
Win %
60%
This Week
Compared To Last Week
Gain
0.91%
Profit
$3.16M
Win %
60%
This Month
Compared to last month
Gain
4.28%
Profit
$14.38M
Win %
60%
This Year
Compared to last year
Gain
3.32%
Profit
$11.27M
Win %
60%
SNDK SanDisk Corporation
+13.67%
+$369,110.48 
MU Micron Technology, Inc.
+4.23%
+$251,242.39 
AMC AMC Entertainment Holdings, Inc.
+3.95%
+$3,722.8 
INTC Intel Corporation
+3.58%
+$120,469.31 
MRVL Marvell Technology, Inc.
+2.35%
+$7,517.4 
QCOM QUALCOMM Incorporated
+1.05%
+$19,162.44 
GOOGL Alphabet Inc
+0.82%
+$97,450.39 
SOXX iShares Semiconductor ETF
+0.76%
+$18,956.75 
BLFS Biolife Solutions Inc.
+0.74%
+$3,019.12 
JBLU JetBlue Airways Corporation
+0.35%
+$254.5 
A Agilent Technologies Inc.
0%
-$0.22 
ABCL AbCellera Biologics Inc.
0%
$0 
ABBV AbbVie Inc.
0%
$0 
ABSI Absci Corporation
0%
$0 
ACI Albertsons Companies, Inc.
0%
$0 
ACHC Acadia Healthcare Company, Inc.
0%
$0 
ADPT Adaptive Biotechnologies Corporation
0%
$0 
AEP American Electric Power Company, Inc.
0%
$0 
ALNY Alnylam Pharmaceuticals Inc
0%
$0 
ARGX argenx SE American Depositary Receipt
0%
$0 
ARWR Arrowhead Pharmaceuticals Inc.
0%
$0 
AVTR Avantor Inc.
0%
$0 
AXSM Axsome Therapeutics, Inc.
0%
$0 
BBIO BridgeBio Pharma, Inc.
0%
$0 
BDN Brandywine Realty Trust
0%
$0 
BE Bloom Energy Corporation
0%
$0 
BIIB Biogen Inc.
0%
$0 
BLTE Belite Bio, Inc.
0%
$0 
BMRN Biomarin Pharmaceutical Inc.
0%
$0 
BNTX BioNTech SE
0%
$0 
BRKR Bruker Corporation
0%
$0 
C Citigroup Inc.
0%
$0 
CAPR Capricor Therapeutics Inc.
0%
$0 
CAT Caterpillar Inc.
0%
$0 
CERT Certara, Inc.
0%
$0 
CHE Chemed Corporation
0%
-$0.13 
CLF Cleveland-Cliffs Inc.
0%
$0 
CME CME Group Inc.
0%
-$0.01 
COO The Cooper Companies, Inc.
0%
$0 
CSGP CoStar Group, Inc.
0%
$0 
CRVS Corvus Pharmaceuticals Inc.
0%
$0 
CYTK Cytokinetics, Incorporated
0%
$0 
CYRX Cryoport Inc.
0%
$0 
DVA DaVita Inc.
0%
$0 
ELVN Enliven Therapeutics, Inc.
0%
$0 
GPN Global Payments Inc.
0%
$0 
GS The Goldman Sachs Group, Inc.
0%
+$1.24 
HPE Hewlett Packard Enterprise Company
0%
$0 
HUM Humana Inc.
0%
+$0.08 
ILMN Illumina, Inc.
0%
$0 
IMVT Immunovant Inc.
0%
$0 
INFY Infosys Limited
0%
$0 
KOS Kosmos Energy Ltd.
0%
$0 
LLY Eli Lilly and Company
0%
-$0.08 
LRCX Lam Research Corporation
0%
$0 
LUMN Lumen Technologies Inc.
0%
$0 
MA Mastercard Incorporated
0%
+$0.01 
MCHP Microchip Technology Incorporated
0%
$0 
MDGL Madrigal Pharmaceuticals, Inc.
0%
$0 
MLTX MoonLake Immunotherapeutics
0%
$0 
MLYS Mineralys Therapeutics, Inc.
0%
+$0.01 
MRNA Moderna, Inc.
0%
$0 
MRVI Maravai Lifesciences Holdings Inc.
0%
$0 
NBIX Neurocrine Biosciences Inc.
0%
-$0.16 
NSC Norfolk Southern Corporation
0%
$0 
NVDA NVIDIA Corporation
0%
$0 
NWL Newell Brands Inc.
0%
$0 
OSCR Oscar Health, Inc.
0%
$0 
OTIS Otis Worldwide Corporation
0%
$0 
PLUG Plug Power Inc.
0%
$0 
PRAX Praxis Precision Medicines Inc.
0%
+$0.02 
PTCT PTC Therapeutics, Inc.
0%
$0 
PTGX Protagonist Therapeutics Inc.
0%
+$0.02 
RARE Ultragenyx Pharmaceutical Inc.
0%
$0 
RMBS Rambus Inc.
0%
-$0.02 
RVTY Revvity Inc.
0%
$0 
SLNCF Silence Therapeutics plc
0%
$0 
SNAP Snap Inc.
0%
$0 
TEVA Teva Pharmaceutical Industries Ltd. ADR
0%
$0 
TNGX Tango Therapeutics Inc.
0%
$0 
TSMWF Taiwan Semiconductor Manufacturing Company Limited
0%
$0 
TWST Twist Bioscience Corporation
0%
$0 
TXG 10x Genomics Inc.
0%
$0 
UTHR United Therapeutics Corporation
0%
$0 
WDC Western Digital Corporation
0%
-$0.01 
XOM Exxon Mobil Corporation
0%
$0 
XRX Xerox Holdings Corporation
0%
$0 
YUMC Yum China Holdings Inc.
0%
$0 
EWT iShares MSCI Taiwan ETF
0%
$0 
FLTW Franklin FTSE Taiwan ETF
0%
$0 
KRE SPDR S&P Regional Banking ETF
0%
$0 
KIE SPDR S&P Insurance ETF
0%
$0 
QQQM Invesco NASDAQ 100 ETF
0%
$0 
TLT iShares 20+ Year Treasury Bond ETF
0%
$0 
XHB SPDR S&P Homebuilders ETF
0%
$0 
XLP Consumer Staples Select Sector SPDR Fund
0%
$0 
XLK State Street Technology Select Sector SPDR ETF
0%
$0 
XLF Financial Select Sector SPDR Fund
0%
$0 
XLRE The Real Estate Select Sector SPDR Fund
0%
$0 
XLI Industrial Select Sector SPDR Fund
0%
$0 
XLU Utilities Select Sector SPDR Fund
0%
$0 
XLV Health Care Select Sector SPDR Fund
0%
$0 
SOC Sable Offshore Corp.
0%
$0 
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)
0%
$0 
GPCR Structure Therapeutics Inc.
0%
$0 
ALMS Alumis Inc.
0%
$0 
CON Concentra Group Holdings Inc.
0%
$0 
ORKA Oruka Therapeutics, Inc.
0%
$0 
BIOA BioAge Labs, Inc.
0%
$0 
CLYM Climb Biotherapeutics, Inc.
0%
$0 
AVR Anteris Technologies Ltd.
0%
$0 
MAZE Maze Therapeutics Inc.
0%
$0 
CCC CCC Intelligent Solutions Holdings Inc.
0%
$0 
INSM Insmed Inc.
-4.5%
-$179,511.5 
COGT Cogent Biosciences, Inc.
-4.28%
-$16,195.66 
SNDX Syndax Pharmaceuticals Inc.
-3.64%
-$9,183.6 
ACAD Acadia Pharmaceuticals Inc.
-3.63%
-$30,735.75 
TAL Tal Education Group
-2.27%
-$4,382.91 
LEGN Legend Biotech Corporation American Depositary Shares
-1.84%
-$8,234.22 
NTRA NATERA INC (Common Stock) – ticker 45E
-1.64%
-$14,576.49 
UNH UnitedHealth Group Incorporated
-1.61%
-$50,000.21 
RVMD Revolution Medicines Inc.
-1.59%
-$19,885.94 
TVTX Travere Therapeutics Inc.
-1.17%
-$40,231.76 
IONS Ionis Pharmaceuticals, Inc.
-0.02%
-$123.38 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 928 | Longs Won 455/928 49% | Profit Factor 1.04 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.01M |
| Average Win $225,328.71 | Best Trade (Mar 31) $11.47M | Sharpe Ratio -1.96 |
| Average Loss -$208,121.9 | Worst Trade (Mar 30) -$16.45M | Z-Score -3.04 (100%) |
| Commissions $0 | Avg. Trade Length 3m 2w 6d | Expectancy $4,399.68 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 0.07% | 0.62% | 2.24% | 5.55% | 11.22% | 19.94% | 32.44% | 49.44% | 71.71% |
| Consecutive Losing Trades | 1,686 | 1,518 | 1,349 | 1,180 | 1,012 | 843 | 675 | 506 | 337 | 169 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies Inc. | 21,826 | $2.9M | $3.24M | - | $336,338.24 | 11.6% | 0.0 |
| ABBV AbbVie Inc. | 11,928 | $3M | $2.97M | - | -$34,352.84 | -1.14% | 0.0 |
| ABCL AbCellera Biologics Inc. | 27,092 | $212,672 | $280,537.66 | - | $67,865.66 | 31.91% | 0.0 |
| ABSI Absci Corporation | 19,712 | $228,462 | $187,264 | - | -$41,198 | -18.03% | 0.0 |
| ACAD Acadia Pharmaceuticals Inc. | 28,725 | $726,743 | $815,215.5 | - | $88,472.5 | 12.17% | -3.633% |
| ACHC Acadia Healthcare Company, Inc. | 66,843 | $1.97M | $2.12M | - | $145,049.1 | 7.35% | 0.0 |
| ACI Albertsons Companies, Inc. | 18,689 | $252,862 | $224,454.89 | - | -$28,407.11 | -11.23% | 0.0 |
| ADPT Adaptive Biotechnologies Corporation | 3,787.25 | $324,946.05 | $95,628.06 | - | -$229,317.99 | -70.57% | 0.0 |
| AEP American Electric Power Company, Inc. | 185,962 | $25.44M | $23.18M | - | -$2.26M | -8.89% | 0.0 |
| ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 5,293 | $2.56M | $1.69M | - | -$869,216.65 | -34% | 0.0 |
| ALMS Alumis Inc. | 15,396 | $359,734 | $393,367.8 | - | $33,633.8 | 9.35% | 0.0 |
| ALNY Alnylam Pharmaceuticals Inc | 5,588 | $1.68M | $1.25M | - | -$430,723.4 | -25.61% | 0.0 |
| AMC AMC Entertainment Holdings, Inc. | 37,228 | $70,733 | $97,909.64 | - | $27,176.64 | 38.42% | +3.953% |
| ARGX argenx SE American Depositary Receipt | 4,392 | $4.07M | $3.85M | - | -$227,374 | -5.58% | 0.0 |
| ARWR Arrowhead Pharmaceuticals Inc. | 5,427 | $442,355 | $473,505.75 | - | $31,150.75 | 7.04% | 0.0 |
| AVR Anteris Technologies Ltd. | 39,233 | $386,445 | $347,996.71 | - | -$38,448.29 | -9.95% | 0.0 |
| AVTR Avantor Inc. | 131,088 | $1.3M | $1.83M | - | $528,284.84 | 40.71% | 0.0 |
| AXSM Axsome Therapeutics, Inc. | 13,831 | $2.34M | $2.97M | - | $631,246.86 | 27% | 0.0 |
| BBIO BridgeBio Pharma, Inc. | 13,454 | $1.01M | $1.13M | - | $120,679.64 | 11.98% | 0.0 |
| BDN Brandywine Realty Trust | 16,416 | $47,116.82 | $51,546.24 | - | $4,429.42 | 9.4% | 0.0 |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for AMY TEH?
The largest contributions to the portfolio's profits come from the following stocks: Johnson & Johnson - $12.19M, SPDR S&P 500 ETF Trust - $4.99M, ASE Technology Holding Co., Ltd. Sponsored ADR - $4.16M, Lumentum Holdings Inc - $3.84M, and Sea Ltd - $3.31M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: Microsoft Corp - $16.32M, QUALCOMM Incorporated - $12.94M, Palantir Technologies Inc - $8.78M, Tesla, Inc - $4.31M, and PayPal Holdings Inc - $4.22M. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does AMY TEH's portfolio generate?
The portfolio generates substantial dividend income, with a total of $4.25M earned over time. The largest contributors to dividend income include Citigroup Inc - $435,872.11, Johnson & Johnson - $418,696.38, The Home Depot, Inc - $369,022.9, QUALCOMM Incorporated - $278,214, and Invesco Senior Loan ETF - $243,514.25. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are AMY TEH's monthly returns?
AMY TEH's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can AMY TEH's strategy be considered aggressive or moderate?
AMY TEH's strategy can be described as moderate. It balances growth potential with risk management, showing a willingness to accept some volatility while still maintaining a relatively structured and diversified approach.
Should beginners follow AMY TEH's strategy?
AMY TEH's strategy is probably not ideal for beginners. The combination of risk, volatility, or portfolio complexity may make it harder to follow and understand without prior experience. Users who are new to investing may find it challenging to replicate or tolerate the performance swings.
